HYA-T

Hyaluronic Acid Regeneration Treatment

• Hyaluronic Acid, low and high molecular weight vectorized hyaluronic acid (LMW / HMW), and neo-hyaluronidase activation peptides association.
• LRCV® (Ligand-Receptor Cell Vector) cellular vectorization technology, using receptor agonist type surface ligands assures a high fibroblast selection.
• At a fibroblast level, Tetrapéptido-50/Heptapéptido-15 association stimulate directly the production of new hyaluronic acid at more than a 100% rate.
• The silinazation process (molecular union with organic silicio) vectors and makes bioavailable the LMW and HMW fractions for base layers in the dermis.